Loading...
Loading...
Among the 5 tracked institutional investors we monitor, MPLT (MAPLIGHT THERAPEUTICS INC) is held with a combined value of $60.98M across 3,117,721 shares. The largest holder is BlackRock, Inc. with a position worth $27.24M (0.00% of their portfolio). VANGUARD GROUP INC opened a new position in the most recent quarter. 3 funds increased their holdings.
Total Institutional Value
$60.98M
Total Shares Held
3,117,721
Institutional Holders
5
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | BlackRock, Inc. | $27.24M | 0.00% | +22.3% |
| 2 | VANGUARD GROUP INC | $15.28M | 0.00% | New |
| 3 | BAKER BROS. ADVISORS LP | $7.41M | 0.04% | - |
| 4 | STATE STREET CORP | $6.89M | 0.00% | +47.8% |
| 5 | FMR LLC | $4.16M | 0.00% | +22521.8% |
As of the latest SEC 13F filings, BlackRock, Inc. is the largest institutional holder of MPLT with a position worth $27.24M, representing 0.00% of their portfolio. In total, 5 institutional investors hold MPLT with a combined value of $60.98M.
In the most recent quarter, 1 fund opened a new position in MPLT. Additionally, 3 increased their holdings.
Institutional investors hold $60.98M worth of MPLT stock across 5 positions. The largest institutional holder is BlackRock, Inc. with $27.24M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For MPLT, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their MPLT positions.